Global Multiplex Assays Market 2026 Edition - Consumables Dominate Multiplex Assays With 68% Market Share

(MENAFN- GlobeNewsWire - Nasdaq) The global multiplex assays market is projected to grow from US$6.8 billion in 2025 to US$12.4 billion by 2030, at a 12.8% CAGR. North America leads with a 34% share, while Asia Pacific is the fastest-growing region at 15.5%; India is forecast to expand at 16.9%. Consumables account for 68% of sales and protein multiplex assays hold 42%. Growth is driven by precision medicine, companion diagnostics, biomarker R&D, molecular diagnostics and laboratory automation. Key players include Thermo Fisher Scientific, Bio-Rad, QIAGEN, Bio-Techne, Revvity, Agilent, BD, Quanterix and Danaher.

Dublin, Sept. 04, 2026 (GLOBE NEWSWIRE) -- The "Global Multiplex Assays Market - 2026 Edition" report has been added to ResearchAndMarkets.com's offering.
This report values the global multiplex assays market at US$6.8B in 2025 and forecasts growth to US$12.4B by 2030, a 12.8% CAGR (2026-2030). North America is the largest regional market at approximately 34.0% share of 2025 demand, while Asia Pacific is the fastest-growing region at approximately 15.5% CAGR, led by China's expanding diagnostics and life-sciences manufacturing base and India's rapid research-infrastructure build-out at approximately 16.9% CAGR - the fastest of any major market covered in this report.
The global multiplex assays market grew from an estimated US$4.1B in 2021 to US$6.8B in 2025, a historical CAGR of approximately 13.5%, as laboratories shifted from singleplex to simultaneous multi-analyte testing to reduce sample volume, cost and turnaround time. By product, consumables (assay kits, reagents, beads and microplates) lead at 68% share, while software and data-analysis services are the fastest-growing category at approximately 16.0% CAGR. By assay type, protein multiplex assays are the largest category at 42% share, while nucleic-acid multiplex assays are the fastest-growing at approximately 14.5% CAGR, driven by molecular-diagnostic panel adoption and next-generation sequencing integration.
Growth is underpinned by the rising global burden of chronic and infectious disease, the expansion of precision medicine and companion diagnostics, increasing biopharmaceutical R&D investment in biomarker-driven drug development, and continued laboratory automation. Key trends reshaping the industry include the scale-up of high-plex and spatial-biology platforms, integration of artificial-intelligence-enabled data interpretation, and the expansion of syndromic and multi-biomarker clinical panels. The market's principal challenges include high instrument and validation costs, assay-development complexity, cross-reactivity and standardization hurdles, and the requirement for specialized personnel and regulatory clearance in clinical settings.
The competitive landscape is led by Thermo Fisher Scientific, Bio-Rad Laboratories, Bio-Techne, QIAGEN, Revvity, Agilent Technologies, Becton, Dickinson and Company, Quanterix and Danaher Corporation, with competitive intensity centered on multiplexing capacity, detection sensitivity, panel breadth and platform automation rather than scale alone. Looking ahead, the global multiplex assays market enters 2026 as a structurally growing industry: precision medicine, expanding companion-diagnostic requirements and continued research investment are together expected to sustain demand for higher-plex, higher-value assay platforms through 2030.

Table of Contents
1. Introduction
1.1 Market Overview
1.2 Definition and Scope of the Report
1.3 Multiplex Assays Industry Value Chain
1.4 Research Methodology
2. Global Market Analysis
2.1 Global Market Snapshot
2.2 Global Multiplex Assays Market Size and Growth, 2021-2030
2.3 Global Multiplex Assays Market Growth Analysis
2.4 Market Drivers
2.5 Market Trends
2.6 Market Challenges and Restraints
3. Market Segmentation
3.1 Market Segmentation Overview
3.2 By Product
3.3 By Assay Type
3.4 By Technology
3.5 By Application
3.6 By End User
4. Regional Market Analysis
4.1 North America - Market Overview & Dynamics
4.1.1 United States
4.1.2 Canada
4.1.3 North America - Country Comparison
4.2 Europe - Market Overview & Dynamics
4.2.1 Germany
4.2.2 United Kingdom
4.2.3 France
4.2.4 Italy
4.2.5 Spain
4.2.6 Europe - Country Comparison
4.3 Asia Pacific - Market Overview & Dynamics
4.3.1 China
4.3.2 Japan
4.3.3 India
4.3.4 South Korea
4.3.5 Australia
4.3.6 Asia Pacific - Country Comparison
4.4 Latin America
4.4.1 Brazil
4.4.2 Argentina
4.5 Middle East & Africa
4.5.1 Saudi Arabia
4.5.2 United Arab Emirates
4.5.3 South Africa
4.6 Global Regional Comparison
5. Technology Landscape
5.1 Multiplex Assays Technology Landscape
5.2 Protein Multiplex Assays
5.3 Nucleic Acid Multiplex Assays
5.4 Cell-Based Multiplex Assays
5.5 Multiplex Assays in Clinical Diagnostics
5.6 Multiplex Assays in Pharmaceutical and Biotechnology R&D
5.7 Competitive Technology Positioning
6. Competitive Landscape
6.1 Competitive Landscape Overview
6.2 Major Companies
7. Company Profiles
7.1 Thermo Fisher Scientific
7.2 Bio-Rad Laboratories
7.3 Bio-Techne
7.4 QIAGEN
7.5 Revvity
7.6 Agilent Technologies
7.7 Becton, Dickinson and Company
7.8 Quanterix
7.9 Danaher Corporation
8. Market Outlook
8.1 Key Market Opportunities
8.2 Emerging Technology Opportunities
8.3 Strategic Recommendations
8.4 Global Market Outlook
List of Tables and Figures
Figure 1 - Global Multiplex Assays Market by Value; 2021-2030 (US$ Billion)
Figure 2 - Global Multiplex Assays Market Year-on-Year Growth Rate; 2022-2030 (%)
Figure 3 - Global Multiplex Assays Market by Product; 2025 (%)
Figure 4 - Global Multiplex Assays Market by Assay Type; 2025 (%)
Figure 5 - Global Multiplex Assays Market by Technology; 2025 (%)
Figure 6 - Global Multiplex Assays Market by Application; 2025 (%)
Figure 7 - Global Multiplex Assays Market by End User; 2025 (%)
Figure 8 - North America Multiplex Assays Market Size & Growth; 2025 & 2030 (US$ Billion)
Figure 9 - United States Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 10 - Canada Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 11 - Europe Multiplex Assays Market Size and Growth; 2025 & 2030 (US$ Billion)
Figure 12 - Germany Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 13 - United Kingdom Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 14 - France Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 15 - Italy Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 16 - Spain Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 17 - Asia Pacific Multiplex Assays Market Size and Growth; 2025 & 2030 (US$ Billion)
Figure 18 - China Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 19 - Japan Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 20 - India Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 21 - South Korea Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 22 - Australia Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 23 - Latin America Multiplex Assays Market Size & Growth; 2025 & 2030 (US$ Billion)
Figure 24 - Brazil Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 25 - Argentina Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 26 - Middle East & Africa Multiplex Assays Market Size and Growth; 2025 & 2030 (US$ Billion)
Figure 27 - Saudi Arabia Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 28 - United Arab Emirates Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Figure 29 - South Africa Multiplex Assays Market by Value; 2025 & 2030 (US$ Billion)
Table 1 - Global Multiplex Assays Market by Assay Type - Value & Growth
Table 2 - North America Multiplex Assays Market by Country
Table 3 - Europe Multiplex Assays Market by Country
Table 4 - Asia Pacific Multiplex Assays Market by Country
Table 5 - Latin America Multiplex Assays Market by Country
Table 6 - Middle East & Africa Multiplex Assays Market by Country
Table 7 - Regional Multiplex Assays Market Comparison
Table 8 - Comparative Overview of Major Multiplex Assay Technologies
Table 9 - Multiplex Assay Technology - Competitive Positioning
Table 10 - Major Multiplex Assay Companies - Global Position & Key Strength
Companies Featured

• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Bio-Techne
• QIAGEN
• Revvity
• Agilent Technologies
• Becton, Dickinson and Company
• Quanterix
• Danaher Corporation

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN04092026004107003653ID1111621266